Insider trading

Period: 120 months Stock: MYO + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

67 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

67 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

67 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

67 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
67 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
67 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

67 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Sep 2026
Kovelman Harry Chief Medical Officer
Sold at will
$19.68K 15,488 at 1.27
14.6%
Not planned
2 Sep 2026
Sold at will
$21.15K 15,000 at 1.41
6.7%
Not planned
20 Aug 2026
Kovelman Harry Chief Medical Officer
Sold at will
$29.90K 17,250 at 1.73
14.0%
Not planned
5 Jun 2026
KIRK THOMAS F Director
Bought
$50.80K 40,002 at 1.27
6.1%
28 May 2026
KIRK THOMAS F Director
Bought
$24.83K 25,000 at 0.99
4.0%
28 May 2026
Kovelman Harry Chief Medical Officer
Sold at will
$11.73K 11,536 at 1.02
9.6%
Not planned
27 May 2026
Kovelman Harry Chief Medical Officer
Sold at will
$20.50K 20,464 at 1.00
14.6%
Not planned
18 May 2026
KIRK THOMAS F Director
Bought
$39.49K 43,401 at 0.91
7.4%
15 May 2026
KIRK THOMAS F Director
Bought
$28.75K 31,605 at 0.91
5.7%
15 May 2026
Manko Joseph M. Jr. Director · indirect
Bought
$26.96K 30,367 at 0.89
1.3%
14 May 2026
Manko Joseph M. Jr. Director · indirect
Bought
$146.95K 170,830 at 0.86
8.1%
First buy on file
16 Mar 2026
Getz Heather C Director
Bought
$13.97K 20,000 at 0.70
17.9%
13 Mar 2026
KIRK THOMAS F Director
Bought
$51.11K 72,000 at 0.71
14.9%
12 Mar 2026
Getz Heather C Director
Bought
$50.96K 70,000 at 0.73
168%
First buy on file
21 Nov 2025
KIRK THOMAS F Director
Bought
$1.83K 2,535 at 0.72
0.5%
20 Nov 2025
KIRK THOMAS F Director
Bought
$3.53K 4,902 at 0.72
1.0%
19 Nov 2025
Crowley Thomas Aloysius Jr. Director · indirect
Bought
$294.53 385 at 0.77
410%
+410% of stake
18 Nov 2025
Bought
$2.94K 4,000 at 0.73
5.6%
First buy on file
25 Aug 2025
KIRK THOMAS F Director
Bought
$57.50K 50,000 at 1.15
11.8%
18 Aug 2025
KIRK THOMAS F Director
Bought
$55.00K 50,000 at 1.10
13.4%
15 Aug 2025
GUDONIS PAUL R Chief Executive Officer
Bought
$47.30K 50,000 at 0.95
4.1%
15 May 2025
KIRK THOMAS F Director
Bought
$119.68K 36,824 at 3.25
12.0%
15 May 2025
GUDONIS PAUL R Chief Executive Officer
Bought
$96.61K 30,000 at 3.22
2.9%
14 May 2025
Mitchell Micah Chief Commercial Officer
Sold at will
$77.69K 90,231 at 0.86
45.2%
Not planned
14 May 2025
KIRK THOMAS F Director
Bought
$6.31K 1,943 at 3.25
0.6%
12 May 2025
KIRK THOMAS F Director
Bought
$167.50K 50,000 at 3.35
19.5%
14 Mar 2025
Mitchell Micah Chief Commercial Officer
Sold at will
$247.56K 48,000 at 5.16
25.5%
Not planned
13 Mar 2025
KIRK THOMAS F Director
Bought
$37.00K 7,400 at 5.00
3.0%
12 Mar 2025
Kovelman Harry Chief Medical Officer
Sold at will
$165.02K 30,000 at 5.50
23.4%
Not planned
5 Sep 2024
Kovelman Harry Chief Medical Officer
Sold at will
$25.18K 6,700 at 3.76
5.1%
Not planned
3 Sep 2024
Kovelman Harry Chief Medical Officer
Sold at will
$8.14K 2,029 at 4.01
1.5%
Not planned
29 May 2024
KIRK THOMAS F Director
Bought
$175.00K 50,000 at 3.50
26.8%
+27% of stake
15 May 2024
Kovelman Harry Chief Medical Officer
Sold at will
$130.84K 35,426 at 3.69
26.5%
Not planned
14 Mar 2024
KIRK THOMAS F Director
Bought
$175.00K 50,000 at 3.50
36.6%
Largest buy in 3 yrs
8 Dec 2023
Sold at will
no price 14,997 shares
33.3%
Not planned
1 Dec 2023
Kovelman Harry Chief Medical Officer
Sold on a plan
no price 8,333 shares
5.6%
Planned (10b5-1)
28 Nov 2023
Sold at will
no price 14,997 shares
25.0%
Not planned
20 Nov 2023
KIRK THOMAS F Director
Bought
$155.00K 50,000 at 3.10
57.8%
First buy on file
8 Sep 2023
Bought
$15.87K 15,000 at 1.06
23.8%
First buy on file
30 Aug 2023
GUDONIS PAUL R Chief Executive Officer
Bought
$36.04K 48,400 at 0.74
5.8%
29 Aug 2023
GUDONIS PAUL R Chief Executive Officer
Bought
$28.80K 37,000 at 0.78
4.7%
29 Aug 2023
HENRY DAVID A Chief Financial Officer
Bought
$25.00K 41,666 at 0.60
13.4%
29 Aug 2023
Kovelman Harry Chief Medical Officer
Bought
$5.00K 8,333 at 0.60
5.9%
First buy on file
28 Aug 2023
GUDONIS PAUL R Chief Executive Officer
Bought
$31.79K 42,500 at 0.75
5.7%
17 Jan 2023
GUDONIS PAUL R Chief Executive Officer
Bought
$100.00K 307,692 at 0.33
175%
Largest buy in 3 yrs
17 Jan 2023
HENRY DAVID A Chief Financial Officer
Bought
$25.00K 76,923 at 0.33
88.8%
Largest buy in 3 yrs
17 Jan 2023
Mitchell Micah Chief Commerical Officer
Bought
$5.00K 15,384 at 0.33
31.1%
First buy on file
22 Nov 2022
HENRY DAVID A Chief Financial Officer
Bought
$4.96K 9,000 at 0.55
11.6%
5 Aug 2022
Sold, plan not stated
$12.22K 7,141 at 1.71
35.6%
14 Jun 2022
Sold at will
$485.39 291 at 1.67
100%
Sold half or more
Showing 1–50 of 67. Page 1 of 2 Older →